That should have said 'by listening to James' . Be careful. A LOT of unethical behavior and manipulation. A lot. I'll never do it again. Let down my guard and whammo-a significant loss fécales I stupidly listened to his concocted bs.
I got very burned by our steaming to James during the last fiasco. Be careful. I wouldn't trust at all.
Now another wrinkle has potentially come to light that may affect the timing of the final resolution (non-CRG related). Nothing is easy with ole Navidea. But at least the tide has finally turned and things are going our way...
Thanks. Where did sales come in at? That quarter should have realized increased revenue based on the alleged great sales team plan.
Given the perpetual messes Navb contributes to, and given the sordid history of companies associated with Platinum's (usually decimated in their wake) and given Platinum's Founder's personal admission that when they see loopholes they take them (with lots of ethical questions)!and given Platinum's closing of varied accounts, and give the multiple (though too late) investigations into Platinum, I wonder:
Was part of Platinum's plan to place the company in severe jeopardy so that Navb would need Platinum's assistance at 14%?
Were they given a dose of their own medicine with CRG's antics?
And/Or, did Navb knowingly make changes that would trigger CRG's actions so that the company might eventually go into crisis or bankruptcy and the SPIN OFF MT's assets would be fought over by a few preferred shareholders? ( I have never been comfortable with M Goldberg's assertion that the 2 million used to start MT was a GIFT. I have never heard of such a thing as gift for source funding , and given Platnum's love for (non ethical? ) loopholes, WHO are first in line to claim the assets of the 'gift'?
I am no paranoid and we lost biiiiiiiig bucks with this orchestrated mess.
Educated comments please.
Exact Sciences Cologuard to receive commercial payor coverage, says Craig-Hallum
After eviCore suggested that Exact Sciences' Cologuard may be considered for colorectal cancer screening once every three years, Craig-Hallum analyst Bill Bonello says he believes that at least one large health insurer, Highmark, has already elected to follow this policy. (OTHERS HAVE INDICATED THEY ARE TOO)'The analyst continues to believe that Cologuard will receive broad commercial payer coverage in light of the 2016 USPSFT final colorectal cancer screening recomendation and that increased payer coverage will drive increased test volumes. He reiterates a Buy rating and $26 price target on the shares.
I am betting that the slash in price today is due to: a)put volume shoving share price down, b) manipulation, and more short covering in between. inreally tend to loathe shorts as they rarely have the company's interest in mind. I believe our stock market is also rigged by huge money interests and lots of spin. Lots. And the SEC: they have shown themselves so often to be so dysfunctional that there us no need for further comment.
You still haven't explained sales doing poorly when the exact opposite is the case. Pleeeeeeze explain. We're depending on your coming through on this.
Your podiatrist could get the same from nail clippings or bunion shaving. Your dentist from gum tissue. Your urologist from uretheoial cells, etc., etc., etc. have a cup of tea and chill,out -- but wash the cup when your done. Chaffed lips leave clues. Oh, and use latex gloves, but burn them after use since skin cells slough off. And, and this is very important, burn your mattress. It's probably filled with traces of you from rubbed off skin, etc. oh, and I forgot your shower drain. Just a small hidden sieve hidden in the drain and.....you're insurance toast.
REGARDING TODAY: Bearish with 2,381 puts trading, or 1.6x expected. Most active are Sep-16 17 puts and Sep-16 20 puts, with total volume in those strikes near 1,400 contracts.